Summary In a retrospective cohort study, the mothers and sisters of 740 breast cancer patients aged under 36 at diagnosis have been studied for mortality and cancer incidence. Significantly increased breast cancer mortality was observed below age 60 (30 deaths; SMR = 3.4), but not at older ages (four deaths; SMR = 0.9). The cumulative breast cancer incidence in the relatives was 3.6% by age 50, 7.6% by age 60 and 11.6% by age 70. They also suffered excess mortality below age 60 for cancers of reproductive sites (cervix, ovary and endometrium; 15 deaths; SMR = 2.6) and lung (11 deaths; SMR = 3.2), but not for other sites (12 deaths; SMR = 0.9). This large population-based cohort study provides further confirmation of genetic susceptibility to breast cancer at young ages.
A family history of breast cancer in a close relative is a well known risk factor for the disease (Kelsey & Gammon, 1990) . Various studies have shown that the risk in first degree relatives is greatest for those with a family history of breast cancer with an early age of onset (Ottman et al., 1986; Claus et al., 1990) . Most such studies are, however, based to some extent on family history as reported by the index case, although cases may have been confirmed by hospital records or death certificates in some studies. Unbiased data on the magnitude of the risk, and on its dependence on age at onset of the index case and her relatives, are needed both for genetic counselling and to elucidate the underlying mechanisms of breast cancer.
In this study, 740 index cases were identified in a population-based case-control study of breast cancer and oral contraceptive use (UK National Case-Control Study Group, 1989) . Details provided by the cases were used to trace their mothers and sisters through the National Health Service Central Register (NHSCR) for mortality and cancer incidence. This tracing procedure provides almost unbiased estimates of mortality and cancer incidence among relatives compared with national rates, and also establishes a prospective cohort for future analysis.
Methods
Case selection and interviewing The methods of case ascertainment and data collection have been fully described elsewhere (UK National Case-Control Study Group, 1989) . All known cases of breast cancer in women aged under 36 diagnosed between January 1, 1982 and December 31, 1985 who were resident in 11 regional health authority areas in Britain were ascertained. Cases were identified primarily through local cancer registries, with additional information from hospital discharge and computerised patient lists at major treatment centres. The study was restricted to white women diagnosed in Britain with no previous malignancy, severe mental handicap or psychiatric condition. All diagnoses were confirmed by pathology report. After obtaining permission from the responsible clinician, the cases were contacted by letter and subsequent telephone call, and were invited to participate in a 'study of women's health'. Cases who initially refused were contacted again 6 months later. Of the total of 1049 cases diagnosed in the study area and period, 16% had died prior to contact, and the clinician refused permission to contact a further 7%. The overall response rate among the remaining 811 cases was 90%. Women who agreed to take part were visited by trained interviewers in their homes.
Family tracing During the routine face to face interview, the cases were asked to provide full names and dates of birth of their mother and any sisters. Only full sisters and natural mothers were included in the cohort.
The mothers and sisters were traced through the NHSCR to obtain details of deaths and cancer registrations. The Department of Health and Social Security Register was also used to trace individuals whose records were not found in the NHSCR. Follow-up for the entire cohort is complete to the end of 1989. Deaths were coded according to the ninth revision of the International Classification of Diseases (ICD).
Statistical methods
As incident cancers were not recorded in the NHSCR before 1971 and registration is not complete thereafter, relative risk estimates are based only on the mortality data. Woman-years at risk were calculated using the 'Person-Years' program, (Coleman et al., 1989) . Follow-up began on their 10th birthday for sisters, and on the date of birth of the case for mothers. Deaths and woman-years after age 85 were ignored. Follow-up closed on December 31, 1989. Expected numbers of deaths were computed using age-, sex-and calendar period-specific mortality rates for England and Wales. Twosided 95% confidence intervals for relative risk estimates are based on the Poisson distribution (Breslow & Day, 1987) .
Results

Follow-up
Of the 755 cases in the original study we excluded 14 who were adopted, and one whose sister was also a case. (To avoid double counting only the elder sister was included.)
The follow up status of the relatives of the remaining 740 cases is shown in Table 1 . Of the 1568 first degree female relatives, 2% (28) had emigrated and 9% (148) were either untraced or had never lived in Britain. One hundred and fifty four had died before the end of 1989, and 1238 were alive. and Wales (dashed line).
Discussion
The results of this study show an increase in breast cancer mortality in women with a history of early-onset breast cancer in a first degree relative as compared to the general population. The increased risk is statistically significant and the relative risk appears to decrease with increasing age of the relative at risk. There is no evidence of an increasing trend in relative risk with reducing age below age 60, as would be expected from the results of other studies. However, the data are clearly consistent with such a trend (for example, the upper 95% confidence limit for the relative risk below age 40 is 7.9). The estimates of risk in first degree relatives of young breast cancer patients obtained in this study are comparable with those reported by others. This is, however, one of the largest studies of familial risks of breast cancer involving such very young cases. Moreover, apart from one Icelandic study (Tulinius et al., 1982) , it is the first study in which all al., 1988) . We therefore believe that our overall results on incidence from all sources, including both traced and untraced relatives in the calculation, are unlikely to be significantly inflated or reduced.
One potential difficulty in this study is the choice of an appropriate control group. Comparisons with national mortality rates might be considered inappropriate for two reasons. First, breast cancer rates varied substantially by social class in the past, which could in principle inflate the observed risks in relatives of cases. The social class gradient has however diminished substantially, and by the 1971 census the SMRs for breast cancer only varied between 117 and 92 for social class I and V respectively. On the basis of these figures (and assuming that social class is the same for different family members) the baseline risk to relatives of a breast cancer case should be increased by less than 2% to allow for social class correlation.* Conversely mothers of cases should have a somewhat lower risk by virtue of the fact that risk is related to parity (MacMahon et al., 1970) . Based on the figures of MacMahon et al. (1970) , this effect should reduce the risk to the mothers of cases by about 13%. Neither of these adjustments is substantial in comparison with the observed familial risks. Moreover, both are irrelevant for the purpose of counselling relatives.
Results from the parent case-control study suggest that any bias in our relative risk estimates due to familial aggregation of other risk factors is likely to be small (UK National Case-Control Study Group, 1989) . Simultaneous adjustment for ten other factors including age of menarche, age at first birth, parity, breast feeding, weight and education made a negligible alteration to the odds ratio associated with family history (2.41 unadjusted, 2.38 adjusted).
The observed excesses of lung cancer and uterine cancer, which were particularly marked below age 50, were somewhat surprising. No evidence of an excess of endometrial cancer in the relatives of breast cancer patients, or vice-versa, were observed in the Cancer and Steroid Hormone casecontrol studies (Schildkraut et al., 1989) . Some supporting evidence for an endometrial cancer excess was found in a population-based study of cancer mortality in relatives of breast cancer cases diagnosed under age 40, in which 13 endometrial cancer deaths were observed as against 5.62 expected (Peto, J., Easton, D.F., Matthews, F.E., Swerdlow, A.J., pers comm). However, this study found little support for an excess of lung cancer (98 deaths versus 101.74 expected overall, and 11 deaths versus 8.26 expected under age 50) or of cervical cancer (five deaths against 9.03 overall, and two against 2.65 below age 50).
Susceptibility to breast and ovarian cancers has recently been shown, by genetic linkage studies, to be the result of a predisposing gene on the long arm of chromosome 17 in some families (Hall et al., 1990; Narod et al., 1991) . In these families the penetrance of the predisposing gene appears to be high. The current study indicates that, even under age 36, only a minority of cases (of the order of 10%) could be due to such highly penetrant genes.
